Member Info for Doc3

Really? You’re glad you’ve been adding over last few weeks? At a premium of nearly 40% to current share price or higher?

When you could have added yesterday for 1.1p?

You’re glad? Are you sure?

The only logical reason for that is that you are accessing the retail offer fully. Is that why you’re glad?

It was 50 nearly 3 years ago.

And it’s had three dilutive raises since then,

50p would require a half billion market cap,

Actually finished better than I expected and raise seemingly well executed.

I assume it will tank at some point later though.

On this are they taking 29.9%.

So do they need a tiny amount more to take over?

Is that a concern?

Agreed.

I think 0.5p by 1630 tomorrow. Then a slow inexorable slide to 0 (accepting shares will consolidate so will be higher).

However AN should be proud. He has delivered an incredible diagnostic platform for the future good of humankind. Sure some share holders (including me) have lost but the good to society is huge. Like railways. Yes investors lost a lot but the USA still got railways. Imagine it like a charitable donation.

You’re probably right.

Me. I’m wiped out. I might sell out tomorrow so that I simply don’t have to think about it anymore.

That doesn’t help the LTH backers of the scatter gun.

But those buying in now. Bravo.

Agreed. If you haven’t held this is a gift.

But if you have it’s awful.

Again. It’ll need 100 million market cap to get to 10p.

2p looks the medium term target. Which is 20 million or 4x what it is today.

EC I admire your relentless optimism.

But this is a total total disaster for long term holders.

To even get to 10p it would need a market cap of 100m.

Please can you just acknowledge how awful this is and let the optimism rest for a few days. At least until tomorrow when the SP will crash below 1p on opening.

And there you have it. Placing 1p.

No premium placing no CLN.

The GBM research is irrelevant.

Just a massively dilutive placing. As predicted.

Assuming they get it away.

3p.

Better than now admittedly.

Off where many thought it would be post fda by a factor of 100x.

With this share almost any news is bad news for the share price.

Certainly price action now, dropped 11% on apparently good news, would support this.

Nothing ever seems to make sense with angle. The only enduring feature is that the sp goes down since May 22, no matter what news.

Https://www.nature.com/articles/s41591-025-03966-3

Used Parsortix

Again I think I’ve seen something about this before? Presentation?

Https://academic.oup.com/neuro-oncology/article/27/Supplement_5/v40/8318109

Uses Parsortix (from company)

I think paper behind previous presentation

That’s fair.

I suppose my point was that if a big company did want to use Parsortix to enrich before their pathways (Roche, Illumina) they don’t need the in cassette stain, they just need the cells. Theyd probably want the faster PX+?

The other thought I had was that product sales have been generally poor. Perhaps they are mostly getting out of the direct product sale business to concentrate on pharma?

One thing that occurs to me is Parsortix plus.

It was in a study in 2023?

From memory it only captures cells you can’t stain etc. but it’s quicker.

Parsortix plus is what you might use for Roche or Illumina to enrich, I think.

Never been released, or even talked about? Unsure why?

Is this real? Surely a desperate action?

Whatever happens EC the tech will survive.

Granted a company could buy it for exclusive use but that would vastly reduce possible revenue.

More likely someone will buy it from the ashes of the company for very little.

A genuine question then.

Given that everyone roughly agrees that a raise sub 1p is reality (or worse), why is anyone invested? Surely the value should be 1p? Which of course will mean a raise is at 0.5p. Unless that is what will happen in next few weeks?

Agreed. The tech will survive: even thrive.

The company though may not survive this fundraise. Altman score -8.

Even if it does small shareholders may be wiped out.